These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 19811812)

  • 1. Consistently very poorly controlled asthma, as defined by the impairment domain of the Expert Panel Report 3 guidelines, increases risk for future severe asthma exacerbations in The Epidemiology and Natural History of Asthma: Outcomes and Treatment Regimens (TENOR) study.
    Haselkorn T; Fish JE; Zeiger RS; Szefler SJ; Miller DP; Chipps BE; Simons FE; Weiss ST; Wenzel SE; Borish L; Bleecker ER;
    J Allergy Clin Immunol; 2009 Nov; 124(5):895-902.e1-4. PubMed ID: 19811812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Asthma Impairment and Risk Questionnaire (AIRQ) Control Level Predicts Future Risk of Asthma Exacerbations.
    Beuther DA; Murphy KR; Zeiger RS; Wise RA; McCann W; Reibman J; George M; Gilbert I; Eudicone JM; Gandhi HN; Ross M; Coyne KS; Chipps B
    J Allergy Clin Immunol Pract; 2022 Dec; 10(12):3204-3212.e2. PubMed ID: 35998877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disease Burden and Long-Term Risk of Persistent Very Poorly Controlled Asthma: TENOR II.
    Haselkorn T; Szefler SJ; Chipps BE; Bleecker ER; Harkins MS; Paknis B; Kianifard F; Ortiz B; Zeiger RS
    J Allergy Clin Immunol Pract; 2020; 8(7):2243-2253. PubMed ID: 32173511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the National Heart, Lung, and Blood Institute guidelines impairment domain for classifying asthma control and predicting asthma exacerbations.
    Zeiger RS; Yegin A; Simons FE; Haselkorn T; Rasouliyan L; Szefler SJ; Chipps BE;
    Ann Allergy Asthma Immunol; 2012 Feb; 108(2):81-7. PubMed ID: 22289725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. More than a decade follow-up in patients with severe or difficult-to-treat asthma: The Epidemiology and Natural History of Asthma: Outcomes and Treatment Regimens (TENOR) II.
    Chipps BE; Haselkorn T; Paknis B; Ortiz B; Bleecker ER; Kianifard F; Foreman AJ; Szefler SJ; Zeiger RS;
    J Allergy Clin Immunol; 2018 May; 141(5):1590-1597.e9. PubMed ID: 28797732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Key findings and clinical implications from The Epidemiology and Natural History of Asthma: Outcomes and Treatment Regimens (TENOR) study.
    Chipps BE; Zeiger RS; Borish L; Wenzel SE; Yegin A; Hayden ML; Miller DP; Bleecker ER; Simons FE; Szefler SJ; Weiss ST; Haselkorn T;
    J Allergy Clin Immunol; 2012 Aug; 130(2):332-42.e10. PubMed ID: 22694932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical burden and predictors of asthma exacerbations in patients on guideline-based steps 4-6 asthma therapy in the TENOR cohort.
    Calhoun WJ; Haselkorn T; Mink DR; Miller DP; Dorenbaum A; Zeiger RS
    J Allergy Clin Immunol Pract; 2014; 2(2):193-200. PubMed ID: 24607048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High use of health services in patients with suboptimal asthma drug regimens: a population-based assessment in British Columbia, Canada.
    Zhang T; Smith MA; Camp PG; Carleton BC
    Pharmacoepidemiol Drug Saf; 2013 Jul; 22(7):744-51. PubMed ID: 23559540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Real life data on incidence and risk factors of severe asthma exacerbations in children in primary care.
    Engelkes M; Janssens HM; de Ridder MA; Sturkenboom MC; de Jongste JC; Verhamme KM
    Respir Med; 2016 Oct; 119():48-54. PubMed ID: 27692147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Change in asthma control over time: predictors and outcomes.
    Schatz M; Zeiger RS; Yang SJ; Chen W; Crawford W; Sajjan S; Allen-Ramey F
    J Allergy Clin Immunol Pract; 2014; 2(1):59-64. PubMed ID: 24565770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Asthma exacerbation rates in adults are unchanged over a 5-year period despite high-intensity therapy.
    Schatz M; Meckley LM; Kim M; Stockwell BT; Castro M
    J Allergy Clin Immunol Pract; 2014; 2(5):570-4.e1. PubMed ID: 25213050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent asthma exacerbations predict future exacerbations in children with severe or difficult-to-treat asthma.
    Haselkorn T; Zeiger RS; Chipps BE; Mink DR; Szefler SJ; Simons FE; Massanari M; Fish JE
    J Allergy Clin Immunol; 2009 Nov; 124(5):921-7. PubMed ID: 19895984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent asthma exacerbations: a key predictor of future exacerbations.
    Miller MK; Lee JH; Miller DP; Wenzel SE;
    Respir Med; 2007 Mar; 101(3):481-9. PubMed ID: 16914299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Very Poorly Controlled Asthma in Urban Minority Children: Lessons Learned.
    Butz AM; Bellin M; Tsoukleris M; Mudd SS; Kub J; Ogborn J; Morphew T; Lewis-Land C; Bollinger ME
    J Allergy Clin Immunol Pract; 2018; 6(3):844-852. PubMed ID: 28958744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design and baseline characteristics of the epidemiology and natural history of asthma: Outcomes and Treatment Regimens (TENOR) study: a large cohort of patients with severe or difficult-to-treat asthma.
    Dolan CM; Fraher KE; Bleecker ER; Borish L; Chipps B; Hayden ML; Weiss S; Zheng B; Johnson C; Wenzel S;
    Ann Allergy Asthma Immunol; 2004 Jan; 92(1):32-9. PubMed ID: 14756462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Economic burden of impairment in children with severe or difficult-to-treat asthma.
    Szefler SJ; Zeiger RS; Haselkorn T; Mink DR; Kamath TV; Fish JE; Chipps BE
    Ann Allergy Asthma Immunol; 2011 Aug; 107(2):110-119.e1. PubMed ID: 21802018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Burden of Chronic Oral Corticosteroid Use by Adults with Persistent Asthma.
    Zeiger RS; Schatz M; Li Q; Chen W; Khatry DB; Tran TN
    J Allergy Clin Immunol Pract; 2017; 5(4):1050-1060.e9. PubMed ID: 28215604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Asthma Exacerbations and Triggers in Children in TENOR: Impact on Quality of Life.
    Chipps BE; Haselkorn T; Rosén K; Mink DR; Trzaskoma BL; Luskin AT
    J Allergy Clin Immunol Pract; 2018; 6(1):169-176.e2. PubMed ID: 28803186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gaps in Care Among Uncontrolled Severe Asthma Patients in the United States.
    Carr T; Tkacz J; Chung Y; Ambrose CS; Spahn J; Rane P; Wang Y; Lindsley AW; Lewing B; Burnette A
    J Allergy Clin Immunol Pract; 2024 Jul; 12(7):1775-1782.e2. PubMed ID: 38508336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Omalizumab in severe allergic asthma inadequately controlled with standard therapy: a randomized trial.
    Hanania NA; Alpan O; Hamilos DL; Condemi JJ; Reyes-Rivera I; Zhu J; Rosen KE; Eisner MD; Wong DA; Busse W
    Ann Intern Med; 2011 May; 154(9):573-82. PubMed ID: 21536936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.